Subject: Contraceptive Labels to Cite Inability To Stop Sexually Transmitted Diseases Date: Published: 4/9/93 (75 lines) Source: Wall Street Journal. Copyright Dow Jones & Co. Inc. Technology & Health: Contraceptive Labels to Cite Inability To Stop Sexually Transmitted Diseases ---- By Rose Gutfeld Staff Reporter of The Wall Street Journal WASHINGTON -- The Food and Drug Administration, fearful that many young people confuse birth control and safe sex, will require labels on birth-control pills and certain other contraceptives stating that the products don't protect against such sexually transmitted diseases as AIDS. The labels, which will begin appearing in about six months, reflect increasing concern by FDA Commissioner David Kessler and others that many young people mistakenly believe that contraceptives such as the pill guard against AIDS as well as pregnancy. The new action was spurred in part by a recent phone call to FDA officials by a counselor in San Francisco who told of a girl who died of AIDS, never realizing the birth-control pills she had been taking weren't protecting her against the disease. "That story made such an impact on us," Ruth Merkatz, special assistant to the commissioner for women's health, says in an interview. "We recognized we had to do something." Dr. Kessler says, "We have to recognize that as we educate about pregnancy, teenagers also need to know that avoiding pregnancy isn't avoiding sexually transmitting diseases." In addition to the HIV infection that can cause AIDS, such diseases as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, syphilis and others can be spread through sexual contact. The FDA's action follows the recent release of a study by a nonprofit group, the Alan Guttmacher Institute, that criticized federal efforts to attack sexually transmitted diseases. Among other complaints, the group said that while the government does work at controlling the spread of the diseases, it doesn't focus sufficiently on helping individuals prevent infections in the first place. All contraceptives will be required to have a statement about sexually transmitted diseases on the package. Similar information will be contained in leaflets physicians distribute with the products. The required information will vary depending on the product. Oral contraceptives, injectable devices such as Upjohn Co. 's Depo Provera, implantable contraceptives such as American Home Product Corp. 's Norplant, natural skin condoms and intrauterine devices will have to say that the products are designed to prevent pregnancy but don't prevent HIV infection and other diseases. The labeling requirements may ease some opposition to efforts by some birthcontrol advocacy groups to make oral contraceptives available over the counter. Among other objections, opponents of making the pills nonprescription have argued that requiring women to visit physicians ensures that they get needed counseling, including information on how to avoid getting AIDS. Such a change would require FDA approval, however, and Dr. Kessler emphasized that the labeling requirements "have nothing to do" with the issue of whether to allow the pills to be sold over the counter. Labeling on natural skin condoms also will state that consumers should use latex condoms rather than natural skin condoms to reduce the risk of sexually transmitted diseases. Latex condom labeling will be able to say that the products, if used properly, reduce the risk of HIV infection and other diseases. Latex condoms are the only product allowed to make such a claim. The FDA still is considering what action to take regarding the labeling of spermicides, cervical caps, diaphragms and American Home Products' Today brand contraceptive sponge. [This article is made available here by Dow Jones Co. for the personal and non-commercial use of callers to this bbs, in the hope that it will be of some help to those who are suffering from the disease and others who are seeking to help them.]